SWOG clinical trial number
SWOG-7738
Combination Chemotherapy of Pancreatic Adenocarcinoma with 5-Fluorouracil, Mitomycin-C and Streptozotocin
Closed
Abbreviated Title
Combination Chemotherapy of Pancreatic Adenocarcinoma with 5-Fluorouracil, Mitomycin-C and Streptozotocin
Activated
01/17/1978
Closed
04/14/1980
Publication Information Expand/Collapse
1984
Characteristics of long term survivors receiving chemotherapy for pancreatic adenocarcinoma in Southwest Oncology Group (SWOG) studies.
1983
Randomized trial of 5-Fluorouracil and Mitomycin C with or without Streptozotocin for advanced pancreatic cancer.
1981
Randomized comparison of 5-FU and Mitomycin-C (MF) versus GI 5-FU, Mitomycin-C and Streptozotocin (SMF) in pancreatic ademocarcinoma. A Southwest Oncology Group study.